Related Experiment Videos

[Perspectives on pharmacological and clinical benefits from sirtuin 1 activators in oxidative damage]

Canová Nikolina Kutinová1, Norbert Gaier, Hassan Farghali

  • 1Karlova Univerzita v Praze, 1. lékarská fakulta, Farmakologický ustav. ncano@lf1.cuni.cz

Casopis Lekaru Ceskych
|June 12, 2012
PubMed

Insights

This review highlights sirtuin 1 activators for treating oxidative tissue damage. These compounds, both natural and synthetic, show promise as leading drug candidates for new therapies.

Area of Science:

  • Biochemistry
  • Enzymology
  • Pharmacology

Context:

  • Sirtuins are NAD+-dependent enzymes involved in cellular regulation.
  • Oxidative tissue damage is implicated in numerous diseases.
  • Sirtuin 1 (SIRT1) plays a critical role in cellular responses to stress.

Purpose:

  • To review the pharmacological significance of natural and synthetic SIRT1 activators.
  • To explore the potential of these activators as therapeutic agents for oxidative tissue damage.
  • To discuss the role of SIRT1 modulators, such as resveratrol, in drug discovery.

Summary:

  • Sirtuins, conserved NAD+-dependent enzymes, deacetylate histones and lysine residues.
  • This article focuses on major sirtuin 1 activators, both natural and synthetic, evaluated for oxidative tissue damage.
  • The bioactivity of these compounds as lead entities for novel drug development is examined.

Impact:

  • Provides insights into the therapeutic potential of SIRT1 activators.
  • Highlights the importance of understanding sirtuin 1 modulators for future drug development.
  • Suggests new avenues for pharmacological and clinical research in oxidative stress-related conditions.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...